期刊
FUTURE ONCOLOGY
卷 11, 期 10, 页码 1519-1530出版社
FUTURE MEDICINE LTD
DOI: 10.2217/fon.15.43
关键词
breast cancer; chemotherapy; hepatectomy; liver metastases; metastasectomy; resection; survival; surgery
类别
Introduction: Liver metastases from breast cancer (BCLM) confer poor survival. Liver resection in BCLM patients has been increasingly employed. Aim: We undertook a systematic review to evaluate the role of hepatic resection in patients with breast cancer metastatic to the liver. Materials & methods: In total, 36 studies were overviewed. Patient populations, characteristics, morbidity, mortality and survival were documented. Results: Median overall survival was 41 months. Major morbidity was rare while 30-day postoperative mortality was near nil. Conclusion: Liver surgery for BCLM can be performed with low mortality, acceptable morbidity and promising survival benefit in carefully selected patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据